Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects von Schneider, Frank, Erisson, Lavi, Beygi, Hooman, Bradbury, Margaret, Cohen‐Barak, Orit, Grachev, Igor D., Guzy, Serge, Loupe, Pippa S., Levi, Micha, McDonald, Mirna, Savola, Juha‐Matti, Papapetropoulos, Spyros, Tracewell, William G., Velinova, Maria, Spiegelstein, Ofer

Volltext

Long-term efficacy, safety, and tolerability of three-times weekly dosing regimen of glatiramer acetate in relapsing-remitting multiple sclerosis patients: 5-year results of the Gl... von Alexander, Jessica, Beygi, Hooman, Feldman, Peter, Ashtamker, Natalia

Volltext

Retrospective safety assessment of bendamustine in patients with renal impairment von Nordstrom, Beth L, Knopf, Kevin B., Teltsch, Dana, Engle, Robert, Beygi, Hooman, Sterchele, James A.

Volltext

Demographics, Treatment Patterns, Safety, and Real-World Effectiveness in Patients ≥70 Years of Age with Chronic Lymphocytic Leukemia Receiving Bendamustine with or without Rituxim... von Kolibaba, Kathryn S., Joshi, Avani D., Sterchele, James A., Forsyth, Michael, Alwon, Erin, Beygi, Hooman, Kennealey, Gerard T.

Volltext

Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without r... von Kolibaba, Kathryn S., Sterchele, James A., Joshi, Avani D., Forsyth, Michael, Alwon, Erin, Beygi, Hooman, Kennealey, Gerard T.

Volltext